PharmacyCodes



Cefaloglycinum [INN-Latin] en es it fr

Cefaloglycinum [INN-Latin] Brand names, Cefaloglycinum [INN-Latin] Analogs

Cefaloglycinum [INN-Latin] Brand Names Mixture

  • No information avaliable

Cefaloglycinum [INN-Latin] Chemical_Formula

C18H19N3O6S

Cefaloglycinum [INN-Latin] RX_link

No information avaliable

Cefaloglycinum [INN-Latin] fda sheet

Cefaloglycinum [INN-Latin] msds (material safety sheet)

Cefaloglycinum [INN-Latin] Synthesis Reference

No information avaliable

Cefaloglycinum [INN-Latin] Molecular Weight

405.426 g/mol

Cefaloglycinum [INN-Latin] Melting Point

237 oC

Cefaloglycinum [INN-Latin] H2O Solubility

154 mg/L

Cefaloglycinum [INN-Latin] State

Solid

Cefaloglycinum [INN-Latin] LogP

-0.256

Cefaloglycinum [INN-Latin] Dosage Forms

No information avaliable

Cefaloglycinum [INN-Latin] Indication

For treatment of severe infections caused by susceptible bacteria.

Cefaloglycinum [INN-Latin] Pharmacology

Cephaloglycin is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C.

Cefaloglycinum [INN-Latin] Absorption

Well absorbed following oral administration.

Cefaloglycinum [INN-Latin] side effects and Toxicity

Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefaloglycinum [INN-Latin] Patient Information

No information avaliable

Cefaloglycinum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria